(137) Percutaneous acetic acid injection in the treatment of hepatocellular carcinoma in cirrhotic patients
β Scribed by A. El Akkaoui; O. Derdabi; M. Benazzouz; O. Essamri; I. Benelbarhdadi; F.Z. Ajana; R. Afifi; A. Essaid
- Book ID
- 119184197
- Publisher
- Elsevier
- Year
- 2009
- Tongue
- English
- Weight
- 49 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1687-1979
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
This study was intended to compare the survival rates of two contemporary cohorts of patients with solitary hepatocellular carcinomas 5 4 cm subjected to surgical resection (n = 33) or percutaneous ethanol injection (n = 30). Outcomes in a third cohort, 21 patients with hepatocellular carcinoma who
achieve complete necrosis of HCC. [9][10][11][12][13][14] The long-term survival To assess the efficacy of ultrasound-guided percutanerate for patients with large HCC after TAE is low. [15][16][17] Thus, ous acetic acid (15%, 20%, 30%, 40%, and 50% in concenthere is a strong demand for other effecti
cirrhosis diagnosis. Furthermore, the posttreatment parameters of the AFP level 1 tolica del Sacro Cuore, Rome, Italy. month after PEI and recurrence of HCC in the same liver segment were also 2 Divisione di Gastroenterologia, IRCCS Casa evaluated. Sollievo della Sofferenza, San Giovanni Rotondo #